← Open Payments lookup

AMREEN AZIZ: Open Payments

NPI 1750701173 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,893 in 95 payments from 23 companies in 2025. Trend: 2023 $1,778 · 2024 $2,023 · 2025 $1,893

Food & beverage: $1,893
CompanyPaymentsAmount
ABBVIE INC.17$277
AstraZeneca Pharmaceuticals LP10$215
Amgen Inc.13$214
Novo Nordisk Inc8$182
Lilly USA, LLC7$135
GlaxoSmithKline, LLC.6$133
Abbott Laboratories5$104
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$88
PFIZER INC.3$61
Boehringer Ingelheim Pharmaceuticals, Inc.3$59

Products named: AIRSUPRA, TRELEGY ELLIPTA, QULIPTA, EVENITY, FREESTYLE LIBRE 3, Ozempic, VRAYLAR, CAPLYTA.

Industry payments across MD — which companies pay providers there.